Back
Hansa Biopharma AB Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
HNSBF
Hansa Biopharma AB
Last Price:
$2.90
Seasonality Move:
-1.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and HNSBF is experiencing slight buying pressure.
Hansa Biopharma AB Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.9 | Sell |
| 20-day SMA: | 2.9 | Sell |
| 50-day SMA: | 2.9 | Sell |
| 200-day SMA: | 3.11 | Sell |
| 8-day EMA: | 2.85 | Buy |
| 20-day EMA: | 2.32 | Buy |
| 50-day EMA: | 1.37 | Buy |
| 200-day EMA: | 0.43 | Buy |
Hansa Biopharma AB Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 5.84 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.9 - 2.9) | Sell |
| Bollinger Bands (100): | (2.91 - 2.91) | Sell |
Hansa Biopharma AB Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Hansa Biopharma AB Stock
Is Hansa Biopharma AB Stock a Buy?
-
Hansa Biopharma AB share price is 2.90 while HNSBF 8-day simple moving average is 2.90, which is a Sell signal.
-
The stock price of HNSBF is 2.90 while Hansa Biopharma AB 20-day SMA is 2.90, which makes it a Sell.
-
Hansa Biopharma AB 50-day simple moving average is 2.90 while HNSBF share price is 2.90, making it a Sell technically.
-
HNSBF stock price is 2.90 and Hansa Biopharma AB 200-day simple moving average is 3.11, creating a Sell signal.
HNSBF Technical Analysis vs Fundamental Analysis
Sell
18
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy or a Sell?
-
Hansa Biopharma AB stock is rated a SellThe current Hansa Biopharma AB [HNSBF] share price is $2.90. The Score for HNSBF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Hansa Biopharma AB Stock Info
Market Cap:
289.2M
Price in USD:
2.90
Share Volume:
0
Hansa Biopharma AB 52-Week Range
52-Week High:
4.58
52-Week Low:
2.73
Sell
18
Hansa Biopharma AB (HNSBF)
is a Sell
Hansa Biopharma AB Share Price Forecast
-
What is the Hansa Biopharma AB stock price today?The Hansa Biopharma AB stock price is 2.90 USD today.
-
Will HNSBF stock go up or go down?Hansa Biopharma AB> share price is forecast to RISE/FALL based on technical indicators
-
Is Hansa Biopharma AB overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hansa Biopharma AB is overvalued.
Is Hansa Biopharma AB Stock a Buy?
-
Hansa Biopharma AB share price is 2.90 while HNSBF 8-day exponential moving average is 2.85, which is a Buy signal.
-
The stock price of HNSBF is 2.90 while Hansa Biopharma AB 20-day EMA is 2.32, which makes it a Buy.
-
Hansa Biopharma AB 50-day exponential moving average is 1.37 while HNSBF share price is 2.90, making it a Buy technically.
-
HNSBF stock price is 2.90 and Hansa Biopharma AB 200-day simple moving average is 0.43, creating a Buy signal.
Technical Analysis of Hansa Biopharma AB
Should I short Hansa Biopharma AB stock?
-
HNSBF Moving Average Covergence Divergence (MACD) indicator is 0.65, suggesting Hansa Biopharma AB is a Buy
-
Hansa Biopharma AB Relative Strength Index (RSI) is 5.84, which suggest Hansa Biopharma AB is oversold
-
The Bollinger Bands (25) for Hansa Biopharma AB is (2.9 - 2.9), which suggest Hansa Biopharma AB is a Sell
-
The Bollinger Bands (100) for Hansa Biopharma AB is (2.91 - 2.91), which suggest Hansa Biopharma AB is a Sell
* Hansa Biopharma AB stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.